2025 AI Stock Picks: 2 Hidden Gems Under $10/Share

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]

John Schmieder Biography and Net Worth

Director of Mesa Laboratories

Mr. Schmieder has experience in corporate finance, public accounting, and investment banking, and is now the owner of multiple holistic health clinics in St. Louis, Missouri, opening the first in 2005. Between 2006 and 2010, Mr. Schmieder also served as the President and Treasurer of the Acupuncture Association of Missouri. He worked at George K. Baum & Co. and Citizens Funds (which became Sentinel Investments) from 1998 to 2003. From 1995 to 2002, Mr. Schmieder served as an equity and financial analyst at May Department Stores (now Macy’s Corporation). From 1990 to 1993, Mr. Schmieder served in various positions, including senior auditor, at Arthur Andersen & Co. He received a Bachelor of Administration in Business degree from the University of San Diego in 1990, a Master of Business Administration with emphasis in finance and corporate strategy from the University of Michigan-Ann Arbor in 1995 and a Master of Oriental Medicine Degree from the Massachusetts College of Pharmacy and Health Science (formerly New England School of Acupuncture) in 2005.

What is John Bradley Schmieder's net worth?: The estimated net worth of John Bradley Schmieder is at least $6.19 million as of September 15th, 2023. Mr. Schmieder owns 62,760 shares of Mesa Laboratories stock worth more than $6,187,508 as of November 21st. This net worth evaluation does not reflect any other assets that Mr. Schmieder may own. Learn More about John Bradley Schmieder's net worth.
How do I contact John Bradley Schmieder?: The corporate mailing address for Mr. Schmieder and other Mesa Laboratories executives is 12100 W 6TH AVE, LAKEWOOD CO, 80228. Mesa Laboratories can also be reached via phone at (303) 987-8000 and via email at [email protected]. Learn More on John Bradley Schmieder's contact information.
Has John Bradley Schmieder been buying or selling shares of Mesa Laboratories?: John Bradley Schmieder has not been actively trading shares of Mesa Laboratories during the past quarter. Most recently, John Bradley Schmieder sold 1,000 shares of the business's stock in a transaction on Friday, September 15th. The shares were sold at an average price of $123.74, for a transaction totalling $123,740.00. Following the completion of the sale, the director now directly owns 62,760 shares of the company's stock, valued at $7,765,922.40. Learn More on John Bradley Schmieder's trading history.
Who are Mesa Laboratories' active insiders?: Mesa Laboratories' insider roster includes Brian Archbold (SVP), Gregory DiNoia (SVP), Evan Guillemin (Director), David Kelly (Director), Gary Owens (CEO), John Sakys (CFO), John Schmieder (Director), and John Sullivan (Director). Learn More on Mesa Laboratories' active insiders.
Are insiders buying or selling shares of Mesa Laboratories?: During the last twelve months, insiders at the medical instruments supplier sold shares 3 times. They sold a total of 5,517 shares worth more than $642,010.16. The most recent insider tranaction occured on October, 28th when CEO Gary M Owens sold 2,518 shares worth more than $286,095.16. Insiders at Mesa Laboratories own 4.4% of the company. Learn More about insider trades at Mesa Laboratories.
Information on this page was last updated on 10/28/2024.

John Bradley Schmieder Insider Trading History at Mesa Laboratories

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/15/2023	Sell	1,000	$123.74	$123,740.00	62,760
9/13/2023	Sell	3,000	$123.32	$369,960.00	66,760
1/13/2023	Sell	1,571	$191.31	$300,548.01	68,976
11/11/2022	Sell	2,500	$175.45	$438,625.00	68,976
1/3/2022	Sell	1,000	$327.77	$327,770.00
8/11/2021	Sell	800	$278.06	$222,448.00	70,707
2/10/2021	Sell	1,750	$278.23	$486,902.50	71,717
1/12/2021	Sell	477	$285.23	$136,054.71	73,467
2/19/2020	Sell	1,800	$266.46	$479,628.00	73,437
11/25/2019	Sell	700	$238.06	$166,642.00	75,119
2/8/2019	Sell	2,500	$232.70	$581,750.00	75,939
2/8/2018	Sell	3,000	$132.27	$396,810.00	77,869

John Bradley Schmieder Buying and Selling Activity at Mesa Laboratories

Mesa Laboratories Company Overview

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Today's Range

Now: $98.81

$98.81

$98.85

50 Day Range

MA: $122.05

$98.59

$135.91

2 Week Range

Now: $98.81

$83.68

$141.17

Volume

2,138 shs

Average Volume

41,102 shs

Market Capitalization

$536.54 million

P/E Ratio

N/A

Dividend Yield

0.64%

Beta

0.87